The Prone Position in Covid-19 Affected Patients (PRON-COVID)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04365959 |
Recruitment Status :
Active, not recruiting
First Posted : April 28, 2020
Last Update Posted : November 9, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Sars-CoV2 | Procedure: Prone position |
BACKGROUND:
It has been shown that the prone position (PP) during mechanical ventilation (VM) in patients with Acute Respiratory Distress Syndrome (ARDS) is able to improve oxygenation and thus reduce mortality.
The reduced mortality, however, is not only caused by an increase in oxygen, but also by the ability of the PP to reduce the damage associated with mechanical ventilation (VILI).
Studies show that the benefits of PP are also present in non-intubated patients; the PP prevents the need for intubation and the consequent risk deriving from the procedure itself and from the predisposition to develop superinfections (VAP).
Moreover, a reduction in the need for intubation and therefore hospitalization in the ICU would be particularly useful in a context of great health emergency with limited resources.
The objective of the study is to value the ability of the prone position to increase the oxygenation of the patient with SARS-cov-2 pneumonia as a lung recruitment index.
STUDY DESIGN:
This is a monocentric study that will be conducted on all patients admitted to the Infectious Diseases and UTIR units of the S. Gerardo Hospital in Monza with the diagnosis of related COVID pneumonia requiring oxygen support or CPAP.
Sample size (n. Patients): 56
The duration of enrollment is estimated in 1 month. Patients will be monitored until discharged from the hospital. The overall duration of the study is estimated to be 1 year (including enrollment, follow up and data analysis).
The patient will be enrolled in the study when consent is obtained. The following data will be collected:
- Patient registration
- Demographic and anthropometric data
- Comorbidity and lifestyle habits
- Hospitalization data
- Blood chemistry tests
- Ventilation parameters
After 10 minutes and at the end of pronation, the feasibility of pronation and ventilation parameters will also be assessed.
STATISTICAL ANALYSIS:
Clinical data relating to enrolled patients will be analysed by means of descriptive statistics on continuous quantitative variables using indicators chosen on the basis of the distributional form. Categorical variables will be described in percentages. Hypotheses on PaO2 / FiO2 performance will be verified through the T test for paired data if the distributional form allows it or alternatively the Wilcoxon test will be used. In this case we will proceed with a recalculation of the power study.
Study Type : | Observational |
Actual Enrollment : | 56 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Study of the Feasibility and Usefulness of the Prone Position in Patients With Respiratory Distress From Covid-19 Not Intubated, in Spontaneous Breath in Oxygen Therapy or Cpap |
Actual Study Start Date : | March 20, 2020 |
Actual Primary Completion Date : | April 9, 2020 |
Estimated Study Completion Date : | December 31, 2020 |
Group/Cohort | Intervention/treatment |
---|---|
covid-19 pneumonia related patients
This study will be conducted on all patients admitted to the Infectious Diseases and UTIR units of the S. Gerardo Hospital in Monza with the diagnosis of related COVID pneumonia requiring oxygen support or CPAP.
|
Procedure: Prone position
The objective of the study is to value the ability of the prone position to increase the oxygenation of the patient with SARS-cov-2 pneumonia as a lung recruitment index; the PP also prevents the need for intubation and the consequent risk deriving from the procedure itself and from the predisposition to develop superinfections (VAP).
Other Name: PP |
- Number of patients in whom the prone position caused an increase in oxygenation [ Time Frame: Until patient discharge from the hospital (approximately 1 month after enrollment) ]Measure the ability of the prone position to increase the oxygenation of the patient with SARS-cov-2 pneumonia as a lung recruitment index.
- The feasibility of prone position [ Time Frame: Until patient discharge from the hospital (approximately 1 month after enrollment) ]Measure the feasibility of the prone position in terms of patient comfort and health resources in a context of a national health emergency.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Age> = 18 years old or <= 75 years old
- Diagnosis of COVID related pneumonia requiring oxygen or CPAP support
Exclusion Criteria:
- pregnant patients
- patients with impaired consciousness and / or uncooperative
- patients with NYHA class> II
- patients with high proBNP
- patients with COPD
- contraindications evidenced by the physicians

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04365959
Italy | |
ASST Monza | |
Monza, MB, Italy, 20900 |
Principal Investigator: | Giuseppe Foti, Prof. | ASST Monza-University Milano Bicocca |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | University of Milano Bicocca |
ClinicalTrials.gov Identifier: | NCT04365959 |
Other Study ID Numbers: |
PRON-COVID |
First Posted: | April 28, 2020 Key Record Dates |
Last Update Posted: | November 9, 2020 |
Last Verified: | November 2020 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
COVID-19 sars-covid-2 |